FTM
First Turn Management Portfolio holdings
AUM
$536M
This Quarter Return
+6.37%
1 Year Return
+36.36%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$615M
AUM Growth
+$615M
(-8%)
Cap. Flow
-$21.9M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
40.68%
Holding
44
New
10
Increased
7
Reduced
15
Closed
8
Top Buys
| 1 |
Insmed
INSM
|
$21.7M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$19.9M |
| 3 |
Merus
MRUS
|
$19M |
| 4 |
Intuitive Surgical
ISRG
|
$18.6M |
| 5 |
Establishment Labs
ESTA
|
$16.8M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$31.9M |
| 2 |
Transmedics
TMDX
|
$23.7M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$21.8M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$18.3M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$15.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biohaven
BHVN
$1.71B
| $12.7M | 2.07% |
366,019
-66,323
| -15% | -$2.3M |
|
27
Apogee Therapeutics
APGE
$2.27B
| $12.5M | 2.04% |
318,327
-61,476
| -16% | -$2.42M |
|
28
KalVista Pharmaceuticals
KALV
$713M
| $12.5M | 2.03% |
1,059,540
-119,880
| -10% | -$1.41M |
|
29
Rocket Pharmaceuticals
RCKT
$358M
| $12.1M | 1.96% |
560,989
+310,119
| +124% | +$6.68M |
|
30
Spyre Therapeutics
SYRE
$1.02B
| $10.9M | 1.78% |
464,435
| – | – |
|
31
Oric Pharmaceuticals
ORIC
$1.03B
| $10.7M | 1.74% |
1,515,960
+418,389
| +38% | +$2.96M |
|
|
SLN
32
Silence Therapeutics
SLN
$237M
| $10.2M | 1.66% |
+537,338
| New | +$10.2M |
|
33
Immunocore
IMCR
$1.78B
| $9.86M | 1.6% |
291,086
-103,588
| -26% | -$3.51M |
|
34
Enliven Therapeutics
ELVN
$1.24B
| $9.66M | 1.57% |
+413,243
| New | +$9.66M |
|
35
Vera Therapeutics
VERA
$1.47B
| $7.7M | 1.25% |
212,944
+94,684
| +80% | +$3.43M |
|
36
Disc Medicine
IRON
$2.14B
| $6.26M | 1.02% |
138,907
-113,766
| -45% | -$5.13M |
|
37
EyePoint Pharmaceuticals
EYPT
$827M
| – | – |
-585,447
| Closed | -$12.1M |
|
|
38
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-421,487
| Closed | -$18.3M |
|
|
39
Day One Biopharmaceuticals
DAWN
$766M
| – | – |
-1,318,207
| Closed | -$21.8M |
|
40
Legend Biotech
LEGN
$6.64B
| – | – |
-228,251
| Closed | -$12.8M |
|
41
Tyra Biosciences
TYRA
$657M
| – | – |
-381,210
| Closed | -$6.25M |
|
42
Viking Therapeutics
VKTX
$3.02B
| – | – |
-128,064
| Closed | -$10.5M |
|
|
VRNA
43
Verona Pharma
VRNA
$9.18B
| – | – |
-973,130
| Closed | -$15.7M |
|
|
SWAV
44
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-98,111
| Closed | -$31.9M |
|